Axel Dignaß
IBD Essentials
We are dedicated IBD clinicians and researchers trying to bring you the latest updates in science and teaching of GI endoscopy. Host Axel Dignaß and his co-hosts Ailsa Hart, Iris Dotan and Florian Rieder speak with renown guest from all over the world. We are grateful to our sponsors abbvie and Olympus.
Wo hören?
Podcasts in der App Replaio Radio Bald verfügbarPodcasts kommen bald in die App. Installiere sie jetzt und erlebe als Erster einen ganz neuen Blick auf Podcasts
Folgen
Special Aspects of IBD management in the Middle-East and career pathways of women in GI and IBD 01.07.2026 22:54
Dr. Sara El Ouali, UAE, talks about the rise of IBD in the mid-east, special aspects of IBD management in the Middle-East and career pathways of women in GI and IBD, including gender disparities, difficult career paths for women and barriers of women in their career and the importance of mentoring programs
Biography and credos of Jean-Fred Colombel and strategies for prevention and very early modification of IBD 24.06.2026 24:24
Jean-Fred Colombel, Mount Sinai Hospital New York City, USA, talks about his biography and personal pathway in IBD and options of very early diagnosis of IBD and strategies to prevent the onset of IBD (interception) and early management of IBD
Biography of Bruce Sands and breaking the therapeutic ceiling in IBD 10.06.2026 24:05
Bruce Sands, Mount Sinai Hospital New York City, USA, talks about his biography and personal pathway in IBD and options of breaking the therapeutic ceiling in IBD including combination therapy, treat to target and early treatment
Management of postoperative Crohn's disease 27.05.2026 24:03
Matthieu Allez, Montreal, talks about the management of postoperative Crohn's disease, prediction of relapse rates, monitoring strategies in the postoperative setting, risk factors for postoperative recurrence and potential strategies to prevent recurrence
Recent BSGE guidelines of chromoendoscopy 13.05.2026 20:15
Pradeep Bhandari from Portsmouth (UK) on recent BSGE guidelines of chromoendoscopy, co-hosted by Raf Bisschops.
Recent clinical trial results informing clinical decision making for vedolizumab and anti-IL23 therapies 29.04.2026 23:56
Dr. Remo Panaccione, an internationally recognized expert in clinical trials discusses the recent data on vedolizumab and anti-IL23 therapies and how those changes impact clinical decision making in IBD
Relevance of cell-based therapies in IBD including hematopoetic stem cell transplantation and CAR T cell therapies 15.04.2026 24:24
Matthieu Allez, Montreal talks about cell-based therapeutic approaches in refractory or complicated IBD covering hematopoetic stem cell transplantation and CAR T cell therapies, indication for this treatment options, success rates and potential side effects and potential future approaches
Discussion about the role of B cells in health and other autoimmune diseases with highlighting the recent groundbreaking observations of B cell directed CART cell therapy in IBD 01.04.2026 29:29
Dr. Saurabh Mehandru, Mount Sinai Hospital in New York, internationally recognized physician scientist in IBD and global leader in B cell biology in intestinal health and inflammation discussed the role of B cells in intestinal homeostasis and IBD. Highliy relevant episode about a novel therapy that is entering IBD.
Introduction of Ailsa Hart as Co-Host of IBD Essentials and Management of Perianal Crohn's disease 18.03.2026 25:59
Ailsa Hart, St. Marks Hospital, London, UK, internationally renowned IBD expert talks about strategies to optimize the management of perianal fistulising Crohn's disease, relevance of MDT approaches, building international consortia, classification and optimized management of perianal fistulising CD
Introduction of Florian Rieder as Co-Host of IBD Essentials and Fibrosis in IBD: A new target for evaluation and treatment 04.03.2026 23:46
Florian Rieder from Cleveland Clinic, Cleveland, USA, internationally renowned IBD and intestinal fibrosis expert talks about his fundamental work and participation in intestinal fibrosis, spanning from basic research, clinical evaluation including establishing a fibrosis PRO, work on international consensus to evaluate intestinal fibrosis and new treatment options for intestinal fibrosis
How medical guidelines can improve the management of IBD 18.02.2026 25:58
Andreas Sturm, gastroenterologist and IBDand medical guideline expert from Berlin, discusses about the development of evidence based guidelines and the relevance to improve the management of patients with IBD and the implementation of guidelines into clinical practice.
Why should students and junior doctors pursue a career in IBD and how can UEG help? 04.02.2026 22:51
Paulo Sousa from Porto, current chair of the young talent group of UEG, reflects why she decided to become a gastroenterologist and to pursue a career in IBD. She describes how UEG may help tom foster a career in gastroenterology and why it may be useful to engage with UEG beyond UEGW
Emerging relevance of AI in the management of IBD 28.01.2026 25:27
Thomas Rösch, editor of Endoscopy Essentials and intgernationally renowned endoscopists discusses the potential role of AI to evaluate and standardize endoscopic disease activity in IBD and the potential repevance of clinical decision support tools to guide clinicians to choose the best treatment options in IBD patients
Role of nutrition in the etiopathogenesis and treatment of IBD 07.01.2026 25:57
Iris Dotan, Petah Tikva, Israel, former IOIBD president and international renowned expert in IBD and nutrition, discusses the role of nutrition in the pathogenesis of IBD and the potential of nutritional intervention to treat IBD and to modify the natural course of IBD
Highlights of new treatment options for IBD from recent phase II and III trials (Abtect, Gladiator, Astro, Graviti), definitions of mild IBD 19.12.2025 24:26
Silvio Danese, Milan, internationally renowned IBD expert, former ECCO president and UEG Vice president discusses recent data from UEG 2025 on Etrasimod in mild UC (gladiator) and late breaking abstract data on obefazimod in ulcerative colitis
Meet the Editor Axel Dignass of our new series IBD Essentials 05.12.2025 27:28
Axel Dignass, internationally renowned IBD expert and editor of the IBD Essentials vodcast, talks about his career and his plans for the podcast, the team, and upcoming topics
Ähnliche Podcasts
Replaio ist kein Herausgeber von Podcasts; die Namen der Sendungen, Cover und Audioinhalte gehören ihren Autoren und werden über öffentliche RSS-Feeds verbreitet